Kearns-Sayre syndrome

From WikiMD.org
Jump to navigation Jump to search

Kearns-Sayre syndrome (pronunciation: KEERNS-SAYR) is a rare, neuromuscular disorder. It is named after two American ophthalmologists, Thomas Kearns and George Pomeroy Sayre, who first described the condition in 1958.

Etymology

The syndrome is named after Thomas Kearns and George Pomeroy Sayre, who first described the condition in 1958. The term "syndrome" is derived from the Greek word "syndromē," which means "concurrence of symptoms," or "running together."

Definition

Kearns-Sayre syndrome is a mitochondrial disease, which means it is caused by mutations in the mitochondrial DNA. It is characterized by progressive weakness and wasting of the skeletal muscles, particularly those muscles that control eye movement (ophthalmoplegia) and eyelid drooping (ptosis). Other symptoms may include heart block, retinitis pigmentosa, and cerebellar ataxia.

Symptoms

The symptoms of Kearns-Sayre syndrome typically appear before the age of 20 and may include:

Diagnosis

Diagnosis of Kearns-Sayre syndrome is based on clinical symptoms and confirmed by genetic testing to identify mutations in the mitochondrial DNA.

Treatment

There is currently no cure for Kearns-Sayre syndrome. Treatment is symptomatic and supportive, and may include physical therapy, speech therapy, and occupational therapy. In some cases, pacemakers may be used to treat heart block.

See also

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski